Ismael Moguel-Garcia

Madrid, MD 28041, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Long-Term Adherence to Benralizumab and Sustained Clinical Benefits in Patients with Severe Eosinophilic Asthma: Insights from GALERNA, a Retrospective Real-World Study in Spain.

Long-Term Adherence to Benralizumab and Sustained Clinical Benefits in Patients with Severe Eosinophilic Asthma: Insights from GALERNA, a Retrospective Real-World Study in Spain.

Journal: Journal of clinical medicine

Published: May 15, 2026

Tezepelumab in the Framework of Use in Special Situations Before Commercialization: T-ROSS, a Retrospective Real-world Study in Spain.

Tezepelumab in the Framework of Use in Special Situations Before Commercialization: T-ROSS, a Retrospective Real-world Study in Spain.

Journal: Clinical therapeutics

Published: January 22, 2026

Severe Asthma and Chronic Rhinosinusitis With Nasal Polyps: Simultaneous Response to Dupilumab.

Severe Asthma and Chronic Rhinosinusitis With Nasal Polyps: Simultaneous Response to Dupilumab.

Journal: Journal of investigational allergology & clinical immunology

Published: January 13, 2026

Expert review and recommendations on the diagnosis and therapeutic management of eosinophilic granulomatosis with polyangiitis.

Expert review and recommendations on the diagnosis and therapeutic management of eosinophilic granulomatosis with polyangiitis.

Journal: Frontiers in immunology

Published: January 12, 2026

A Multi-Compartment Cytological Approach to Severe Asthma Phenotyping: The BRISA Study (Biomedical Research in Severe Asthma).

A Multi-Compartment Cytological Approach to Severe Asthma Phenotyping: The BRISA Study (Biomedical Research in Severe Asthma).

Journal: Journal of asthma and allergy

Published: January 10, 2026

Editorial comment on "Early-life allergic sensitization and respiratory infection-Two hits on lung function?"

Editorial comment on "Early-life allergic sensitization and respiratory infection-Two hits on lung function?"

Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

Published: September 04, 2025

Benralizumab is effective in severe asthma with CRS, regardless of demographic and clinical basal outcomes.

Benralizumab is effective in severe asthma with CRS, regardless of demographic and clinical basal outcomes.

Journal: Allergologia et immunopathologia

Published: June 27, 2025

Fixed Airflow Limitation in Severe Asthma: Rethinking the Role of Small Airway Disease.

Fixed Airflow Limitation in Severe Asthma: Rethinking the Role of Small Airway Disease.

Journal: Open respiratory archives

Published: May 18, 2025

Aspergillus fumigatus Serum IgG Cut-Off for the Diagnosis of Aspergillus-Associated Lung Disease: A Historic Cohort Analysis.

Aspergillus fumigatus Serum IgG Cut-Off for the Diagnosis of Aspergillus-Associated Lung Disease: A Historic Cohort Analysis.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: January 03, 2025

Personalized Medicine in Severe Asthma: Bridging the Gaps.

Personalized Medicine in Severe Asthma: Bridging the Gaps.

Journal: Open respiratory archives

Published: November 01, 2024

Allergic bronchopulmonary aspergillosis: A treatable trait to consider in chronic obstructive pulmonary disease?

Allergic bronchopulmonary aspergillosis: A treatable trait to consider in chronic obstructive pulmonary disease?

Journal: Medicina clinica

Published: August 20, 2024

Cutaneous reactions during Helicobacter pylori eradication therapy referred to an allergy department.

Cutaneous reactions during Helicobacter pylori eradication therapy referred to an allergy department.

Journal: Allergy

Published: July 16, 2024

Showing 1-12 of 37

Last Updated: 09/26/2026